Ubrelvy 100 MG tablet UD 16S
Ended Awarded
- Contract number
- SPE2DB25FMVZR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,393
Award facts
- Contract value 100% obligated
- $3,392.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,392.62 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-count unit dose packaging) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist used for acute migraine treatment, reflecting the Defense Logistics Agency's pharmaceutical supply mission for military healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded delivery orders demonstrates its capability as a critical vendor within the federal medical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FMVZR?
SPE2DB25FMVZR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FMVZR worth?
The government has obligated $3,393 on SPE2DB25FMVZR.
Is contract SPE2DB25FMVZR an order under another contract?
Yes. SPE2DB25FMVZR is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMVZR competed?
The extent of competition for SPE2DB25FMVZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award